A Phase 1 Open-label Study of KPT-9274 in Patients With Relapsed and Refractory Acute Myeloid Leukemia

Trial Information
Status: Not yet recruiting
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1

This study will evaluate the safety and tolerability of oral KPT-9274 for the treatment of patients with relapsed or refractory acute myeloid leukemia.

Am I eligible for this trial?
Who do I contact about this trial?
When is this trial taking place?
How many participants will be in this trial?
What treatment is being studied in this trial?
Who are the authors of this trial?
What other conditions are being studied in this trial?

This content was sourced from clinicaltrials.gov